At the end of May Indegene and TranScrip launched IntraScience - an innovative regulatory, safety and medical services solution for global biopharmaceutical companies. The press release focused on the benefits of such an alliance for providing services to facilitate the success of smaller, as well as larger, pharma companies to gain the same cost advantages.
TranScrip, is a renowned global provider of scientific support throughout the product lifecycle, and Indegene is a leading provider of clinical, commercial, and marketing solutions to life science, pharmaceutical, and healthcare organisations. For TranScrip the change will be transformational, enabling them to fulfil their passion to extend their support to innovative healthcare. TranScrip is now uniquely poised to support a full range of scientific, medical and high volume operational activities in drug development and safety.